Skip to main content
logo
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.1114
0.00 (0.00%)
Sep 11, 2026, 5:35 PM CET

GenSight Biologics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
26233326155255
Market Cap Growth
11.69%-30.35%28.79%-83.46%-39.23%-16.09%
Enterprise Value
37424946147220
Last Close Price
0.110.100.270.463.365.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
40.0635.3112.598.6631.9033.13
PB Ratio
-1.05-0.92-1.23-0.84-10.1615.97
P/TBV Ratio
-----16.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
56.0964.0518.5915.5330.2528.53

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.52-0.52-0.53-0.77-1.171.10
Net Debt / Equity Ratio
-0.42-0.42-0.44-0.70-0.47-1.67
Net Debt / EBITDA Ratio
-0.95-0.95-0.81-0.78-0.270.99
Net Debt / FCF Ratio
-1.14-1.14-0.92-0.87-0.211.56
Asset Turnover
0.070.070.260.170.120.15
Quick Ratio
0.320.320.200.180.962.18
Current Ratio
0.390.390.240.261.572.40
Return on Equity (ROE)
-----7781.69%-206.34%
Return on Assets (ROA)
-72.68%-72.68%-99.39%-105.83%-42.13%-33.80%
Return on Capital Employed (ROCE)
250.50%250.50%133.30%183.80%-246.30%-81.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-46.08%-52.29%-42.36%-102.16%-17.80%-11.21%
FCF Yield
-35.12%-39.85%-39.14%-96.14%-21.91%-6.72%
Buyback Yield / Dilution
-54.91%-54.91%-98.18%-4.29%-2.61%-28.54%